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Abstract
Escherichia coli amine oxidase (ECAO), encoded by the tynA gene, catalyzes the oxidative
deamination of aromatic amines into aldehydes through a well-established mechanism,
but its exact biological role is unknown. We investigated the role of ECAO by screening
environmental and human isolates for tynA and characterizing a tynA-deletion strain using
microarray analysis and biochemical studies. The presence of tynA did not correlate with
pathogenicity. In tynA+ Escherichia coli strains, ECAO enabled bacterial growth in phenyl-
ethylamine, and the resultant H2O2 was released into the growth medium. Some aminogly-
coside antibiotics inhibited the enzymatic activity of ECAO, which could affect the growth of
tynA+ bacteria. Our results suggest that tynA is a reserve gene used under stringent envi-
ronmental conditions in which ECAOmay, due to its production of H2O2, provide a growth
advantage over other bacteria that are unable to manage high levels of this oxidant. In addi-
tion, ECAO, which resembles the human homolog hAOC3, is able to process an unknown
substrate on human leukocytes.
Introduction
Primary amine oxidases (EC 1.4.3.21, PrAOs, also known as copper-containing amine oxi-
dases, CAOs) are expressed in mammals, plants, and bacteria. These enzymes catalyze the oxi-
dation of primary amines into aldehyde through the reaction R-CH2-NH2 + O2 + H2O!
R-CHO + H2O2 + NH3. The preferred amine substrate depends on the specific amine oxidase,
and the aldehyde product depends on the substrate [1]. The by-products of the reaction, hydro-
gen peroxide and ammonia, are invariably released.
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In Escherichia coli (E. coli), a copper amine oxidase (ECAO) is encoded by the tynA gene
(Entrez Gene ID: 945939, previously known asmaoA, [2]). ECAO is a soluble, periplasmic,
homodimeric protein with one copper ion and post-translationally derived topaquinones at
both of its active sites [3]. Aromatic amines are the preferred substrates of ECAO, as compared
to aliphatic amines and polyamines; therefore, it is also called 2-phenylethylamine oxidase or
tyramine oxidase (http://www.expasy.org, [3]). ECAO was originally identified in E. coli K-12
[4], and its expression is detected only when the cells are growing in a medium supplemented
with tyramine or phenylethylamine (PEA); it is not expressed under anaerobic conditions [5].
The expression of ECAO is regulated by FeaR, an AraC family regulator that also activates a
phenylacetaldehyde dehydrogenase–encoding gene, feaB [5]. Because a transposon inserted
into the tynA gene causes a constitutive SOS response [6], which protects against severe DNA
damage caused by ultraviolet light or DNA-damaging chemicals [7], it has been suggested that
tynA could be involved in catabolizing toxic compounds [8].
The crystal structure of ECAO has been solved [9]. It is a prototypic homodimer that has a
catalytic section consisting of the D2–D4 domains and an additional D1 domain that is absent
from other solved copper amine oxidase (CAO) structures. Although ECAO (as well as PrAOs
from Arthrobacter globiformis and Hansenula polymorpha) has been used as a model enzyme
to elucidate the enzymatic mechanism of amine oxidases [10–17], its known biological func-
tions have so far been limited to enabling the bacteria to grow on different carbon or nitrogen
sources [5,9,18]. In mammals, the corresponding primary amine oxidase, hAOC3, is involved
in processes such as leukocyte trafficking and glucose metabolism [19].
In this study, we determined how widely this amine oxidase is found within the bacterial
kingdom and in what circumstances it is expressed. We assessed ECAO’s biological role by per-
forming microarray analysis on a deletion strain of E. coli K-12, ΔtynA. We found that ECAO
can utilize a human leukocyte cell surface molecule(s) as a substrate and is inhibited by a
hAOC3 inhibitor, which suggests that it shares similarities to its human counterpart. These
results broaden our knowledge about this enzyme in bacteria and provide us with new insights
into its role in E. coli.
Materials and Methods
Reagents
All the reagents were from Sigma-Aldrich unless otherwise stated.
Bacterial strains and DNA
The E. coli strains used were DH5α [20], SY327 λpir [21], S17-1 λpir [22], and wild-type (wt) E.
coli strains isolated from different environmental and human sources. Extended-spectrum
beta-lactamase (ESBL) strains and wastewater samples were obtained from the National Insti-
tute for Health and Welfare, Turku, Finland. Bacterial pathogens were obtained from the
Department of Microbiology, University of Turku, Finland. The DNAs of Finnish enterohe-
morrhagic E. coli (EHEC) strains were from the National Institute for Health andWelfare, Hel-
sinki, Finland. The strains of different E. coli pathotypes were from the Institute for Molecular
Infection Biology, University of Würzburg, Germany. E. coli strains isolated from well waters
were obtained from the Finnish Water Protection Association, South-Western Finland, Turku,
Finland. Strains from natural gut microbiota were collected from the fecal samples of healthy
volunteers, and were only used for the development of the cultivation method. Stool samples
analyzed for tynA and ECAO activity were from routine clinical microbiology laboratories.
The vector pUC19 was from Fermentas (Waltham, MA, USA). E. coli (pKK233-3-tynA) [11]
and pRV1 [23] have been characterized before.
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The presence of semicarbazide-sensitive amine oxidases in various
bacteria
The presence of PrAO enzymes in bacteria was studied using two strategies: bioinformatics
and functional assays. In the bioinformatics approach, we searched for bacteria with PrAO
enzymes by querying published bacterial sequences (NCBI The Entrez Protein database) for
established PrAO PROSITE motifs, namely a topaquinone signature (PS01164, LVVrwisTvg-
NYDY) and a copper-binding site signature (PS01165, TtGttHVaraEEwP). In the functional
assay, we cultured 85 different E. coli strains in minimal medium with a specified amine as the
only carbon source and tested the bacterial lysate for the presence of tynA by polymerase chain
reaction (PCR, see below).
Culture conditions
Bacteria were cultured in lysogeny broth (LB, [24]) or on Luria agar plates (LA) supplemented
with the appropriate antibiotics (ampicillin, 25 μg/mL; chloramphenicol, 20 μg/mL; kanamy-
cin, 100 μg/mL in the plates and 20 μg/mL in liquid media). Selected strains were screened for
the expression of tynA by culturing the bacteria in an M9 minimal medium [25] supplemented
with 2 g/L lactose and 5 mM PEA (M9-lactose-PEA medium). To induce ECAO activity, an
overnight culture of wt E. coli in M9-lactose medium was diluted 1:20 in M9-lactose-PEA with
5 μMCuSO4. The bacteria were grown aerobically at 30°C with 250 rpm shaking. The induc-
tion of ECAO was assayed by measuring its activity (see below). To overexpress ECAO, we cul-
tured E. coli (pKK233-3-tynA) in LB supplemented with 5 μMCuSO4 at 37°C and 250 rpm
shaking to early log phase and induced the expression of ECAO by adding isopropyl β-1-D-
thiogalactopyranoside (IPTG) to a final concentration of 2 mM.
PCR screening for tynA
For the tynA screening, we took E. coli samples from fresh LA plates, suspended the bacteria in
water, and incubated the samples for 5 min at 95°C. A total of 1 μL of bacterial lysate was used
for PCR. We used forward primer EAO1 (5`-gacggggcatctttaccac-3`) and reverse primer
EAO2 (5`-cacgccgctgaccgtagg-3`) to detect a 500–base pair (bp) fragment of the tynA gene.
LACYfor (5`-ggtacttcaaacatatgcagcg-3`) and LACYrev (5`-ggctacatgacatcaaccatatc-3`), which
amplify a 900-bp fragment of the E. coli lacY gene, were used as positive controls. Primers were
from Operon (Cologne, Germany), and the Dynazyme polymerase was from Thermo Scientific
(Espoo, Finland). The reaction products were subjected to agarose gel electrophoresis (Qbio-
gene QA-agarose, Qbiogene, Montreal, Canada), stained with ethidium bromide (Bio-Rad,
Hercules, CA, USA), and visualized under ultraviolet light.
Sequencing tynA
The tynA genes from three tynA+ strains that grew in the M9-lactose-PEA medium and five
tynA+ strains that did not grow (indicating the enzyme was inactive) were cloned into the
pCDNA3.1 plasmid and sequenced (Turku Centre for Biotechnology, University of Turku and
Åbo Akademi University, Finland, primer sequences are available on request).
tynA in the E. coli genome
The genomes of tynA+ and tynA- strains were compared using the Artemis Comparison Tool
(ACT) online (http://www.webact.org/, [26]).
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Construction of a tynA knockout strain (ΔtynA)
The tynA gene and 600 bp of flanking sequences on either side were amplified by PCR, using E.
coli K-12 as a template, with the forward primer 5`- GTCAGAGAATTCCACATATGGATAAG
ATTGCTG -3`(EcoRI site in bold) and the reverse primer 5`- TCTGACGGATCCGACACGCTG
GTTAGTGG -3`(BamHI site in bold). The primers were designed according to the published
sequence of the tynA locus in the E. coli genome [27]. The 3740-bp PCR product was cloned into
the EcoRI/BamHI site of pUC19. A tynA fragment of 2250 bp was removed from the plasmid by
inverse PCR (forward primer 5`-CTCAAGATGCATTCAGGTTGTTTTACGGGCAGAATAC-
3`and reverse primer 5`-GTCAGAATGCATGACGAAACGCCAACGCTAG-3`, NsiI sites in
bold). The tynA gene was replaced with a 1200-bp kanamycin resistance cassette (kmGB), which
was a PstI cleavage product from the pUC-4K plasmid (GEHealthcare, Little Chalfont, UK). The
tynAΔkmGB was excised from pUC19 using PvuII, and the blunt ends were ligated into the EcoRV
sites of the pRV1 suicide vector. The restriction enzymes EcoRI, BamHI, and NsiI were fromNEB
(New England Biolabs, Beverly, Massachusetts, USA), and EcoRV and PvuII were from Promega
(Madison, Wisconsin, USA). Digestion products were purified from an agarose gel using the Qia-
gen Gel Extract Kit (Hilden, Germany), and the T4-ligation kit (NEB) was used for ligations.
The pRV1 vector containing the tynA knockout cassette (pRV1-TK) was electroporated
first into SY327 λpir and then into S17-1 λpir. The plasmid was conjugated from S17-1 λpir into
wt ESBL E. coli 201. The transconjugant bacteria, now having the suicide vector integrated into
their genomes by homologous recombination, were subjected to a cycloserine enrichment to
select for clones resistant to kanamycin and ampicillin, and sensitive to chloramphenicol. In
these clones, a second homologous recombination event had eliminated the suicide vector and
the wild-type allele. The constructed mutants were verified by PCR using the primers 200bpFS
(5`-GCAACGGCGAATAGTTGC-3`) and 200bpFSrev (5`-CGGTGTGGGTAAACAGCC-3`),
and by Southern blotting.
Southern blotting
Genomic DNA from wt and ΔtynA E. coli strains was isolated using the NucleoSpin Tissue Kit
(Macherey-Nagel, Dueren, Germany). DNA was digested with HindIII (NEB), and Southern
blotting was performed as described previously [28]. In the wt, the 3400-bp fragment encom-
passing tynA and 600-bp of flanking sequences was labeled using [α-32P]dCTP (50 μCi,
3000 Ci/mmol), according to the Prime-a-Gene Labeling System (Promega, Madison, WI,
USA). The probe was purified using a ProbeQuant G-50 Micro Column, and the hybridization
was performed in ULTRAhyb hybridization buffer (Ambion, Foster City, CA USA) at 42°C for
14–16 h. Probe detection was performed using X-ray film. The exposure time was 3 h.
Preparation of cell lysates
Bacterial cultures were centrifuged at 3200 × g at 4°C for 15 min, and cell pellets were lysed in
phosphate-buffered saline (PBS) containing 1 mM phenylmethylsulfonyl fluoride (PMSF), 1%
aprotinin, and 0.1% nonyl phenoxypolyethoxylethanol (NP-40). The cells were lysed by three
freeze-thaw cycles using liquid nitrogen and a 37°C water bath. The crude lysates were further
treated with short ultrasound pulses (2 × 15 s).
Determination of protein concentration
The concentration of protein within the lysates was determined using the Bio-Rad DC Protein
Assay, with bovine serum albumin as the standard. The concentration of a purified protein was
determined by a Bradford assay (Bio-Rad).
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Amine oxidase activity assay
To determine the amine oxidase activity in the lysates, we utilized the Amplex Red assay
(Molecular Probes Europe BV), using 10 μg of bacterial lysate per well. PEA (0.5 mM) was
used as a substrate. To specifically determine semicarbazide-sensitive amine oxidase activity,
we used 1 mM semicarbazide (SC) in the control wells. ECAO activity was measured as the dif-
ference in fluorescence between SC-inhibited and uninhibited samples. To test two new sub-
strates, isoamylamine and propylamine, we used the same assay and identical amounts of
substrate. The activity assays were performed at 30°C.
To test if ECAO has a substrate on human granulocytes, we used purified recombinant pro-
tein ECAO, whose production and purification has been described [9]. To collect human neu-
trophils, we extracted granulocytes from the fresh peripheral blood of healthy volunteers using
Ficoll (GE Healthcare). We collected buffy coats according to standard procedure, lysed red
blood cells with Pharm Lyse (BD Biosciences, Franklin Lakes, NJ, USA), washed with PBS,
counted the cells, and used the cells immediately. The assay was conducted in 25 mMHEPES
and 150 mMNaCl (pH 7.4), and we used 30 nM ECAO and 200,000 viable granulocytes per
well. PEA was used as a positive control for the substrate, and the specific activity was deter-
mined using parallel wells with SC, as described above. The assay was conducted at 37°C.
Three independent assays (different blood donors) were performed with duplicates.
ECAO inhibitor tests
To determine the effect of different inhibitors on ECAO activity, we used purified ECAO pro-
tein and a spectroscopic amine oxidase activity assay, which is not as sensitive to additives as
the Amplex Red assay [29]. In short, 21 ng of ECAO protein was incubated with differing
amounts of inhibitors in Krebs-Ringer phosphate glucose buffer for 20 min at 30°C. After incu-
bation, we added substrate (0.5 mM PEA) and a mixture of 1 mM vanillic acid, 0.5 mM 4-ami-
nopyridine, and 16 U of horseradish peroxidase, and measured the A492nm immediately and
hourly thereafter.
To assess the effect of inhibitors on bacterial growth, discs with different concentrations of
SC were placed on LA plates freshly plated with either tynA+ E. coli (three different strains) or
tynA- E. coli (five strains). The inhibition zones were measured the next day. For the growth
inhibition assay in a liquid medium, the same strains were cultured in tryptic soy broth (TSB)
medium for 14–16 h. Then, 103 cells were inoculated into TSB medium with different concen-
trations (0–100 mg/mL) of SC and cultured further at 37°C with shaking at 100 rpm until the
following day. Then, 10 μL of bacterial mixture was plated on lactose medium plates, and the
plates were incubated at 37°C for 14–16 h before counting the colonies.
The inhibition of growth by a selective hydrazine-based human amine oxidase inhibitor,
BTT-2052 [30], and SC on tynA+ and tynA- strains was tested similarly in M9-lactose-PEA
medium using inhibitor concentrations of 0–0.5 mM.
RNA extraction
To extract RNA from the bacteria cultured in M9-lactose-PEA medium, we added two volumes
of RNA Protect Bacteria (Qiagen) immediately to samples taken from the E. coli cultures at 0 h,
1 h, and 4 h. Total RNA was isolated using the RNeasy Mini-Kit (Qiagen), and DNA was
removed using the RNase-Free DNase Set (Qiagen). The concentration of the extracted RNA
was determined by a NanoDrop 2000 (Thermo Scientific), and the quality of RNA was quanti-
fied by Bio-Rad’s Experion electrophoresis station.
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cDNA preparation and array hybridization
Microarray studies were performed at the Finnish DNAMicroarray Centre at Turku Centre
for Biotechnology, Turku, Finland. Standard microarray methods were used for cDNA synthe-
sis, fragmentation, and end-terminus biotin labeling, and were based on Affymetrix protocols.
Equal amounts of total RNA from seven different samples were pooled to yield the required
10 μg of starting material, and 2.4 μg of fragmented and labeled cDNA was used in the prepara-
tion of the hybridization cocktail. The cocktail was prepared according to the Midi format.
Each sample was hybridized to the GeneChip E. coli 2.0 Array. A GeneChip Fluidics Station
450 was used to wash and stain the arrays, and a GeneChip Scanner 3000 with Autoloader was
used to scan the arrays. Affymetrix GeneChip Command Console (AGCC) software version
1.0 was used to control the Fluidic Station and Scanner. CEL files were automatically generated
by AGCC. After the hybridization, quality control was done with the Affymetrix Expression
Console.
Data analysis
All the microarray data analysis was done using the R language and environment for statistical
computing and Bioconductor [31,32]. The array data was normalized with the gcRMAmethod
[33]. The resulting data was filtered using a threshold of>2.5 and<-2.5 for the fold-change of
up- and down-regulated genes, respectively. The microarray data discussed here has been
deposited in NCBI's Gene Expression Omnibus [34] and are accessible through GEO Series
accession number GSE65385 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE65385).
Production of hydrogen peroxide in the medium by ECAO
Wt ECAO was induced in M9-lactose-PEA medium cultures as described above. The ΔtynA
strain was used as a negative control, and the cultures were grown for 6 h, as described. The
cells were separated by centrifugation (1.5 min at 15300 × g), and the supernatant was assayed
for activity by measuring the amount of hydrogen peroxide in the medium using the Amplex
Red assay and by measuring the fluorescence using a fluorometer (TECAN Ultra, Tecan,
Zürich, Switzerland).
Ethics
For the cultivation of tynA+ strains, as well as for measuring ECAO activity, we used collec-
tions of bacterial specimens that are investigated in routine clinical microbiology laboratories
in Finland. In 2006, when the experiments were done, no ethical approval for the usage of
these bacterial samples was needed, as all of them were from anonymous donors. For the devel-
opment of a method to cultivate specimens from stool under specific conditions, we collected a
few stool samples from the authors, who gave their oral informed consent for the usage of their
samples for this purpose. One of the authors (T.K.) collected, stored, and cultivated the samples
anonymously. We did not collect any identifying information from the donors, and none of
the experiments or results were ever connected to their identities.
Statistical analyses
The data are shown as the mean ± the standard error of the mean (SEM). Statistical tests, unless
otherwise mentioned, were conducted using the Student’s t-test, and a value of p< 0.05 was
considered statistically significant.
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Results
Amine oxidases in various bacteria
To analyze which bacteria could harbor a homolog of PrAO, we conducted a database search
using two PROSITE motifs that defined the active sites and the copper-binding sites of amine
oxidases. The database search revealed that the amine oxidase gene exists in many environ-
mental bacterial species (isolated from soil, sea water, pesticide- and metal-contaminated soil),
as well as in opportunistic pathogens, but it exists in only a few clinically important species (S1
Table).
ECAO in E. coli
The existence of tynA in different E. coli strains was assayed first by screening 38 Finnish waste-
water and well water samples for the presence of tynA using PCR (Table 1, S1 Fig). More than
half of the well water samples (57%) and about one third of the wastewater samples (35%) were
tynA+. The subsequent screening of different human isolates and E. coli pathotypes indicated
that this gene could be frequently detected in diarrhea-causing pathotypes, such as non-O157:
H7 EHECs (82% tynA+), enterotoxigenic E. coli (ETEC; 69%), and enteroinvasive E. coli
(EIEC; 67%), as well as in fecal isolates (38%, Table 2). Of note, tynA was less frequently
detected in enteropathogenic E. coli (EPEC; 17%). Among extra-intestinal pathogenic isolates,
tynA was most frequently detected in sepsis isolates (27%). Out of the few tested pus (7),
wound (3), and blood (8) samples, 71%, 67%, and 50% were tynA+, respectively. The tynA
screening was negative in newborn meningitis (11) and in O157:H7 EHEC (28) isolates.
Genome comparisons
To gain further insight into the evolution of tynA in E. coli, we compared the genomes of a
tynA-positive (K-12) and a tynA-negative (UPEC CFT073) strain with the ACT [26], which
revealed that a 33-kb area flanking the tynA gene is missing from CFT073 (S2 Fig). When
another tynA-negative strain, IHE3034, was included, we found the rearrangement of 930 kb of
flanking sequence by an inversion.
Table 1. Frequency of E. coli in environmental isolates.a
Waste water Well water
Total 20 18
tynA+ 7 12
% 35 57
atested by PCR.
doi:10.1371/journal.pone.0142367.t001
Table 2. Frequency of E. coli in human isolates.a
Wound Pus Blood Sepsis Feces EIEC EPEC UPEC ETEC NBM EHEC O157:H7 EHEC Non-O157:H7
Total 3 7 8 15 99 3 6 45 13 11 28 49
tynA+ 2 5 4 4 38 2 1 3 9 0 0 40
% 67 71 50 27 38 67 17 7 69 0 0 82
atested by PCR.
doi:10.1371/journal.pone.0142367.t002
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Natural tynAmutations
When screening for culture conditions that induced tynA expression, we found that ECAO
activity was induced only when tynA+ strains were grown with PEA as the carbon source (data
not shown). However, when we tested the amine oxidase activity of several strains that were
tynA+, according to our PCR screening, some did not grow in M9-lactose-PEA medium. Only
a subset (22 out of 39 tynA+ strains) both grew and had amine oxidase activity, as determined
in our standard Amplex Red assay (S2 Table). The sequencing of tynA genes from seven
strains, both inactive and active, demonstrated that four strains, including DH5α, had muta-
tions in tynA when compared to the tynA of wt E. coli K-12, but none of the mutations were in
the conserved residues essential for amine oxidase activity (S3 Table). Therefore, we propose
that the presence of tynA does not necessarily reflect the existence of the functional enzyme.
ECAO expression and activity depends on the presence of both lactose
and PEA in the medium
To study the biological role of tynA in E. coli K-12, we constructed a tynA-deletion strain
(ΔtynA) through allelic exchange. The successful allelic exchange was verified by PCR, and the
deletion of tynA was confirmed by Southern blot (S3 Fig).
We assayed the expression and activity of the tynA gene product, ECAO, on PEA in differ-
ent media. When culturing wt bacteria in M9-lactose-PEA medium, we detected activity on
PEA (5 mM) after 1 h, and the activity reached a maximum at 2 h after induction (Fig 1A). No
significant activity was detected in M9-PEA medium supplemented with another sugar, such
as glucose, arabinose, rhamnose, sucrose, or maltose, as a carbon source (data not shown). To
analyze the relationship between ECAO expression and the presence of both lactose and PEA
in the medium, we tested the amine oxidase activity of wt and ΔtynA strains in minimal
mediumM9 supplemented with lactose, with or without 5 mM PEA. We detected a clear
dependence of activity on the presence of lactose and PEA for wt, but the ΔtynA strain had no
activity in either (Fig 1B), which has been shown before with a different medium [18]. To
Fig 1. The time andmedium dependence of ECAO expression and activity. (A) The kinetics of ECAO induction in E. coli K-12 (wt) cultured in M9-lactose
medium supplemented with 5 mM PEA (n = 4). The 0 h time point corresponds to the time when the cells were diluted into PEA-containing culture medium.
(B) The activity of ECAO is induced in E. coli K-12 (wt), but not in our ΔtynA strain, by the presence of both lactose and PEA 6 h after diluting the bacterial
cultures in M9-lactose-PEA media (n = 3). (C) The H2O2 production of wt K-12 E. coli and ΔtynA bacteria in stationary phase in M9-lactose-PEAmedium
(** p < 0.01). The means ± SEMs are shown.
doi:10.1371/journal.pone.0142367.g001
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measure the amount of H2O2 released into the medium by ECAO, we measured the H2O2 con-
centrations of stationary phase cultures of wt and ΔtynA strains. Again, the ΔtynA strain failed
to produce any H2O2 in the medium, whereas the wt strain had concentrations of up to 1 μM
H2O2 (Fig 1C), similar to earlier findings [18]. To test the endurance of ECAO expression, a
total of nine different strains (and our ΔtynA strain) were cultured in similar conditions for
7 d, during which the cells continued to grow without entering stationary phase. ECAO activity
remained at a similar level, although it differed among the strains. The ΔtynA strain was con-
stantly inactive (data not shown).
Inhibition of ECAO with semicarbazide
ECAO preferentially processes aromatic amine substrates such as PEA, tyramine, and trypt-
amine, whereas the human homolog of ECAO, hAOC3, is most active towards benzylamine
(BA) and methylamine [3,35]. In our experiments, we confirmed the preferential activity of
ECAO on PEA, tyramine, and tryptamine over BA (S4 Fig). To our knowledge, the effects of
different amine oxidase inhibitors on ECAO have not been tested; therefore, we compared the
effects of a general PrAO inhibitor, SC, and a selective hAOC3 inhibitor, BTT-2052, on ECAO
activity on PEA (Fig 2). Among seven different inhibitor concentrations (0.1–10 μM), we
observed a half maximal inhibitory concentration (IC50) of 0.7 μM for SC and 0.24 μM for
BTT-2052.
We tested the effect of the SC and BTT-2052 inhibitors on the growth of the wt and ΔtynA
strains on plates and in liquid media. When we used SC concentrations lower than 5–10 mM,
we detected no significant effect on growth in liquid rich media (S5 Fig). As expected, SC had
no effect on the growth of the ΔtynA strain (S5 Fig). On LA plates, SC had no effect on bacterial
growth under the concentration of 100 mg/mL, and even at 100 mg/mL, the effect was minimal
(data not shown). BTT-2052 had no effect on the growth of either wt or ΔtynA strains on plates
at the investigated concentrations (0.1–0.5 mM, data not shown).
Certain aminoglycosides are able to inhibit ECAO activity
Aminoglycosides, which consist of branched primary amine groups attached to a ring structure
(tetrahydropyran or cyclohexane), are antibiotics against Gram-negative bacteria and are
reported to inhibit bovine amine oxidase [36]. We tested the effect of aminoglycosides on
ECAO activity; kanamycin, tobramycin, amikacin, and sisomycin (p = 0.06) decreased activity
by 23–61% (Fig 2C). Gentamycin had no effect. To quantify the inhibition kinetics of amikacin,
tobramycin, and kanamycin, we measured the activity of ECAO on PEA in different aminogly-
coside concentrations (10 μM–10 mM). The half maximal inhibitory concentrations (IC50)
were 1 mM for amikacin, 0.8 mM for tobramycin, and 3.8 mM for kanamycin (Fig 2D). The
inhibition kinetics of amikacin and BTT-2052 were compared across nine different inhibitor
concentrations (Fig 2E). The shape of the curves is similar, but the IC50 values differ by an
order of magnitude.
Knocking out tynA interferes with several pathways in E. coli
To assay the biological role of tynA in E. coli, we performed microarray analysis using RNA
from wt and ΔtynA cell lysates. After 4 h of growth in M9-lactose-PEA medium, the most dif-
ferentially expressed gene between ΔtynA and wt was tynA, as expected (214-fold down-regu-
lated, Table 3). In addition, the enzymes involved in the aerobic catabolic pathway of
phenylacetate (paaABCDEFGHIJKXY andmaoC [paaZ]) and phenylacetaldehyde dehydroge-
nase (feaB) were down-regulated (FC = -108 –-2.9, Fig 3A). Furthermore, we noticed a decrease
in the expression of oxyS, grxA, and ahpCF, which are regulated by the oxidative stress
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regulator OxyR [37]; OxyS is a regulatory sRNA, GrxA is a glutaredoxin, and AphCF is an
alkyl hydroperoxide reductase [38–40]. Other genes, which were expressed with less than a
Fig 2. Different ECAO inhibitors. (A) The relative inhibition of ECAO by semicarbazide (SC) and (B) the hAOC3 inhibitor BTT-2052. (C) The effect of
different aminoglycosides (1 mM) on the activity of ECAO (** p < 0.01). (D) The inhibition curves of different aminoglycosides on ECAO activity. (E) The
pairwise comparison of inhibition curves between BTT-2052 and amikacin.
doi:10.1371/journal.pone.0142367.g002
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-2.5-fold difference, were hypothetical proteins c0693 and c4090, and S-adenosyl-L-methio-
nine-dependent methyltransferase (smtA, FC -2.8, -2.8, and -2.9, respectively).
The most up-regulated genes in ΔtynA were those encoding the enzymes involved in oxidiz-
ing propionate to pyruvate: prpBCDE with FC 9.38 to 3.39 (Table 4, Fig 3B). Notably, there
were fewer genes up-regulated than down-regulated, and the magnitude of up-regulation was
lower (the highest fold-change was 9.38, whereas the lowest was -213.77). Two other pairs of
up-regulated genes were those of the nitrogen regulatory protein C (NtrC)–activated polar
amino acid transporter family yhdXZ [42], with FC = 6.09 and 3.44, respectively, and the respi-
ratory nitrate reductase genes narUW [43], with FC = 2.97 and 3.14 respectively. See Table 4
for the other up-regulated genes.
ECAO activity on granulocytes
To determine whether bacterial ECAO could function like its human counterpart, hAOC3, by
acting on human leukocytes, we tested the activity of purified, recombinant ECAO protein [9]
with fresh human granulocytes as the sole source of substrate. We detected significantly more
Table 3. Differentially down-regulated (FC < -2.50) genes in ΔtynA.a
Gene
symbol
Gene FC
tynA Tyramine oxidase, copper-requiring -213.77
pad Predicted multicomponent oxygenase/reductase subunit for phenylacetic
acid degradation
-108.30
paaC Predicted multicomponent oxygenase/reductase subunit for phenylacetic
acid degradation
-86.95
maoC Fused aldehyde dehydrogenase/enoyl-CoA hydratase -83.89
paaA Predicted multicomponent oxygenase/reductase subunit for phenylacetic
acid degradation
-76.72
paaB Predicted multicomponent oxygenase/reductase subunit for phenylacetic
acid degradation
-67.16
paaG Acyl-CoA hydratase -55.67
paaE Predicted multicomponent oxygenase/reductase subunit for phenylacetic
acid degradation
-53.42
paaF Enoyl-CoA hydratase-isomerase -49.38
feaB Phenylacetaldehyde dehydrogenase -39.84
paaI Predicted thioesterase -24.85
paaJ Predicted beta-ketoadipyl CoA thiolase -22.80
paaK Phenylacetyl-CoA ligase -13.82
paaH 3-Hydroxybutyryl-CoA dehydrogenase -13.09
oxyS OxyS RNA -10.16
grxA Glutaredoxin 1 -6.30
paaX DNA-binding transcriptional repressor of phenylacetic acid degradation,
aryl-CoA responsive
-4.81
smtA Putative metallothionein -2.88
pay Predicted hexapeptide repeat acetyltransferase -2.87
ahpF Alkyl hydroperoxide reductase subunit F -2.85
c4090 Hypothetical protein -2.79
ahpC Alkyl hydroperoxide reductase subunit C -2.76
c0693 Hypothetical protein -2.75
aComparisons to wt bacteria were made at the 4 hr time point
doi:10.1371/journal.pone.0142367.t003
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H2O2 production when granulocytes were added to ECAO than in the condition without cells,
without ECAO, or with SC as an inhibitor (Fig 4). Clorgylin was added to prevent monoamine
oxidase activity.
Discussion
We found that the gene encoding the primary amine oxidase, tynA, is present in various bacte-
ria. We screened several environmental and human isolates for both tynA presence and activ-
ity, and demonstrated that some strains possess the gene, but do not have its activity. We
replicated the previous results that ECAO enables bacteria to grow on a rare nitrogen or carbon
source, such as PEA, and that the activity of the tynA gene product in E. coli periplasm drives
the production and release of hydrogen peroxide into the environment [18]. As new findings,
Fig 3. Pathways altered by tynA knockout. (A) The phenylethylamine metabolic pathway is down-regulated (green) in the ΔtynA strain when compared to
the wt strain in M9-lactose-PEAmedium. (B) The oxidation of propionate to pyruvate is up-regulated (red) in the ΔtynA strain. Pathways are depicted
according to Brock et al. and Zeng et al. [5,41].
doi:10.1371/journal.pone.0142367.g003
Table 4. Differentially up-regulated (FC > 2.50) genes in ΔtynA.a
Gene symbol Gene name FC
prpE Putative propionyl-CoA synthetase 9.38
prpD 2-Methylcitrate dehydratase 8.50
prpC Methylcitrate synthase 7.99
yhdX Putative transport system permease protein 6.09
gabT 4-Aminobutyrate aminotransferase 3.53
yhdZ Hypothetical amino-acid ABC transporter ATP-binding protein YhdZ 3.44
prpB 2-Methylisocitrate lyase 3.39
narW Cryptic nitrate reductase 2 delta 3.14
narU Nitrite extrusion protein 2 2.97
aldB Aldehyde dehydrogenase B (lactaldehyde dehydrogenase) 2.83
pqiA Paraquat-inducible protein A 2.71
hemN Coproporphyrinogen-III oxidase 2.60
ygaM Hypothetical protein 2.53
glgS Glycogen synthesis protein GlgS 2.53
ldhA D-Lactate dehydrogenase 2.50
aComparisons to wt E. coli were done at the 4 h time point.
doi:10.1371/journal.pone.0142367.t004
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we demonstrated that ECAO is inhibited by certain aminoglycosides and report that ECAO
can utilize human leukocytes as substrates. In addition, ECAO was inhibited by a human
amine oxidase inhibitor suggesting that the bacterial protein mimics the enzymatic activity of
the human homolog.
tynA is a reserve gene for harsh culture conditions
Our database search for the existence of tynA revealed that opportunistic pathogens, human
and plant pathogens, antibiotic-producing bacteria, and bacteria resistant to antibiotics harbor
an amine oxidase homolog of ECAO (S1 Table). The environmental bacteria included isolates
from harsh conditions, such as the soil, pesticide- or metal-contaminated soil or seawater, sug-
gesting that tynA serves as a reservoir gene for circumstances when nutrients are not abun-
dantly available. This was supported by our detecting more tynA-positive E. coli strains in well
water than in wastewater (Table 1). On the other hand, the release of hydrogen peroxide into
the immediate environment may be bactericidal to those bacteria that do not express peroxi-
dases, such as catalase in E. coli K-12 [44,45]. As has been shown previously [18], we also mea-
sured hydrogen peroxide at a concentration of 1 μM in the medium of tynA+ bacterial cultures
in stationary phase, and this was tynA dependent (Fig 1). ECAO is a periplasmic enzyme and
the hydrogen peroxide formed by its enzymatic reaction is secreted into the environment,
because the flux of the formed hydrogen peroxide is larger through the outer membrane than
through the inner membrane [18]. Even small amounts of hydrogen peroxide may give a
growth advantage to ECAO-producing bacteria in their immediate surroundings.
O157:H7 E. coli are tynA-negative
We observed the absence of tynA in serotype O157:H7 EHEC (Table 2). Some O157:H7 bacte-
ria lose O157 antigenicity or survive poorly in water cultures [46,47], suggesting that growth
conditions favoring the presence of tynA could be specifically useless or harmful for O157:H7
Fig 4. ECAO is able to use human granulocytes as a substrate.We detected the production of H2O2 by
ECAOwhen granulocytes were the only source of substrate (Cells + ECAO), and the activity was inhibited by
semicarbazide (Cells + ECAO + SC). The activity is significantly higher than without ECAO (Cells only,
p = 0.0003; cells with SC, p = 0.0004; without cells, p = 0.017, and with added SC inhibitor [Cells+ECAO+
SC], p = 0.004). The mean of three independent experiments is shown ± SEM. Statistical significance was
calculated with paired t-test.
doi:10.1371/journal.pone.0142367.g004
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pathogenicity. In addition, PEA inhibits cell division and reduces O157:H7 E. coli counts in
beef [48], which further supports our finding.
ECAO processes aromatic amines and is affected by a human PrAO
inhibitor and aminoglycosides
As a semicarbazide-sensitive amine oxidase, ECAO is able to process PEA, tyramine, and trypt-
amine, and its activity is inhibited by SC, hydroxylamine, phenelzine, iproniazid, and tranycy-
promine [3]. We found that the hAOC3 inhibitor BTT-2052 also inhibited ECAO with an
efficient inhibitor concentration lower than that of SC (0.24 μM vs. 0.7 μM, respectively, Fig
2A and 2B). This is within the same range of IC50 values for recombinant hAOC3, mouse and
rat AOC3, and purified porcine AOC1 (0.05–0.18 μM, [30]). In addition, the IC50 of BTT-2052
for ECAO was lower than that for mouse PrAO, hAOC2, and for recombinant human MAO-A
[30]. We also demonstrated that the aminoglycosides tobramycin, amikacin, and kanamycin
inhibited ECAO activity (IC50 of 0.8–3.8 mM, Fig 2C–2E), which may have some clinical rele-
vance. Although observed IC50 concentrations are one order of magnitude higher than the
maximum concentration recommended for these antibiotics in human serum (2–72 μM), con-
centrations 100 times higher than in serum can be locally achieved, as when antibiotics accu-
mulate in the kidney during their excretion [49].
ECAO is a metabolic enzyme
To analyze the role of ECAO in E. coli K-12, we performed a microarray analysis on the wt and
ΔtynA strain. Most of the down-regulated genes in ΔtynA were either part of the paaABCDEF-
GHIJKXYZ operon, which produces enzymes to convert phenylacetic acid to acetyl-CoA and
succinyl-CoA, or were related to it (tynA and feaB) and were active in utilizing PEA as a carbon
source (Fig 3A, [50,51]). Another down-regulated group of genes were those under the control
of OxyR (oxyS, aphCF, and grxA), which is present in its inactive, reduced form in vivo [52].
OxyR is activated by hydrogen peroxide, and once oxidized, drives the transcription of oxyS,
ahpCF, and grx, among other genes [52,53]. Furthermore, ΔoxyR cells are unable to grow on
PEA, but grow on phenylacetic acid [18]. Because we observed no down-regulation of the
other members of the regulon [54], the down-regulation of oxyS, aphCF, and grxAmost likely
results from the activation of OxyR by the hydrogen peroxide produced by ECAO. In addition,
there was no significant difference in the levels of the cyclic adenosine monophosphate
(cAMP) or the cAMP regulatory protein (CRP) genes (cyaA, FC 1.21 and crp FC 1.11, respec-
tively), despite paaABCDEFGHIJK and paaZ being regulated by CRP [55–57]. This is sup-
ported by the recent results that paaXY, which were both down-regulated in our work, form an
auto-regulated operon, and PaaY regulates the transcription of other paa genes [58]. The roles
of the rest of the down-regulated genes in ΔtynA remain to be elucidated.
In the ΔtynA strain, the prpBCDE operon was up-regulated. Its proteins are involved in
degrading propionate to pyruvate in the 2-methylcitrate pathway ([41], Fig 3B). The prpBCDE
operon is activated by carbon catalytic repression, which ensures the utilization of the most
energy-rich sugar (glucose) in the growth environment via regulation by cAMP, CRP, and σ54
([55,59–61]). We believe that when tynA+ E. coli strains are grown in PEA-lactose minimal
medium, this operon is down-regulated, enabling the utilization of PEA. When PEA cannot be
utilized by the ΔtynA strain, the repression of the operon is not active, and the genes are up-
regulated compared to the wt strain. Previously, it was shown that prpBCDE is down-regulated
by 2 g/L lactose in rich culture medium [62], and we found this is also true for minimal
medium. The fourth enzyme involved in the 2-methylcitrate pathway, acnB, was only slightly
up-regulated (FC 1.6), but it is expressed in all growth conditions, independent of the energy
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source [41]. Two other genes related to the propionate pathway were also up-regulated in
ΔtynA cells: ldhA, whose gene product, lactate dehydrogenase, converts pyruvate to lactate [63]
and aldB, which encodes for an enzyme that converts propanal to propionate [64].
Nitrogen starvation can induce tynA expression [5]. Therefore, the up-regulation of genes
in ΔtynA could result from the absence of ammonia produced by ECAO in wt cells. Of note,
narWU and yhdXZ genes were up-regulated in the ΔtynA strain. Both yhdX and yhdZ are acti-
vated by nitrogen limitation [42,65]. In addition, narU, which is involved in nitrate uptake
[66], and narW, which is needed in the formation of active respiratory nitrate reductase com-
plex NRZ from the narZYWV operon [43], were up-regulated. The NarY subunit of the com-
plex contains an iron-sulfur cluster, and the formation of such clusters are catalyzed, in
anaerobic conditions, by an oxygen-independent coproporphyrinogen-III oxidase, a gene
product of hemN [67], which was also up-regulated in the ΔtynA strain. Moreover, prpBCDE,
yhdXZ, and hemN are all under the control of the RNA polymerase subunit σ54, which is
important in nitrogen assimilation [61].
Finally, glgS was also up-regulated. It encodes for a glycogen synthesis molecule that is
induced during stationary phase and may be a significant repressor of bacterial adhesion and
biofilm formation [68]. Its up-regulation in ΔtynA cells could simply be a consequence of more
stringent culture conditions. In conclusion, the microarray analysis of up-regulated genes in
the ΔtynA strain identified new genes involved in PEA-dependent nitrogen utilization and con-
firm the metabolic pathways affected by the lack tynA.
It has been known for a long time that PrAOs are involved in amine metabolism. It is an
advantage for bacteria to be able to grow on different nutrients. For example, Klebsiella oxytoca,
E. coli, and Arthrobacteria use oxidases to grow on, preferably, aromatic amines [3,69,70].
Arthobacter globiformis has two different oxidases, enabling it to grow on both PEA and hista-
mine [71,72], and Arthrobacter P1 is able to grow on methylamine [73]. This capability is not,
however, restricted to bacteria. Yeasts have been proposed to use these enzymes in their metab-
olism [74,75]. Eukaryotic PrAOs, in general, have markedly different substrate specificity than
prokaryotes, as they process BA and methylamine over other substances like tyramine or PEA
[76–78], but their biological functions differ from those of prokaryotes [77,79].
ECAO can use human granulocytes as a substrate
The human counterpart of ECAO, hAOC3, is involved in the adhesion and transmigration of
leukocytes from blood vessels to the sites of inflammation [80]. hAOC3 utilizes lymphocyte
surface molecules as a substrate, and Siglec-9 and -10 (Sialic acid–binding immunoglobulin-
like lectins) are its leukocyte counter-receptors [81–83]. The activity of hAOC3 is important
for its biological role in leukocyte trafficking [84]. Because ECAO is inhibited by a hAOC3
inhibitor and has a similar molecular structure, we tested ECAO’s activity on human leuko-
cytes. Indeed, purified recombinant ECAO was able to process human granulocytes, as deter-
mined by the production of H2O2 (Fig 4), even though we and others have demonstrated
different substrate specificities for these two proteins [3,76]. Although it is possible that puri-
fied PrAOs from other bacteria, plants, and yeast can also process molecules on human granu-
locytes, we demonstrated that E. coli ECAO behaves in a similar manner as hAOC3 under
these experimental conditions, yet the in vivo relevance remains to be seen.
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